- Mar 17, 2017
- Reaction score
I think i read that it’s an almost $2 billion contract.
As i type this , PFE is only $38 a share.. i wonder if it wouldnt be a bad idea to sort of ‘hedge one’s bet’ by buying into Pfizer, Moderna and AstraZeneca, the three most promising vaccines I’ve read about recently.. of course would probably lose your shirt on two out of three, but if one of those companies comes up with THE vaccine, then that would more than make up for it.. or is that a rookie mistake? Also, hopefully multiple companies will come up with successful vaccines, so there’s that.
I set a small limit order at 37.65 which filled today. So probably a rookie mistake. I see a 4% dividend and a chance at a big government contract. If their phase 3 trial works out well, then maybe they run up. If it runs up, I can sell and take profit. If it holds, I get the dividend. If their trial fails, it's a small enough buy that I can live with a loss.
It's a $2B contract for 100M doses and has an option to purchase 500M additional doses. If the vaccine doesn't reach the market, PFE gets nothing. If it goes to market, then I think the US will be taking the 500M option. I think China and India vaccines aren't leaving those countries until their needs are met. So even if a US company is late to produce, there still will be demand.